openPR Logo
Press release

Kidney Disease Market Report: Trends, Production, Revenue, Growth And Forecast To 2032

Kidney Disease Market

Kidney Disease Market

The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company's Kidney Disease Global Market Report 2023 identifies increased incidence of kidney diseases as the major driver for the Kidney Disease market's growth in the forecast period. Kidney diseases refer to a group of conditions that affect the function and structure of the kidneys. Kidney disorder medications are used to lower patients' blood pressure and reduce protein loss, slowing the progression of kidney damage, managing symptoms, and preventing complications.

The global kidney diseases market size is expected to grow from $92.26 billion in 2022 to $99.22 billion in 2023 at a compound annual growth rate (CAGR) of 7.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The size of kidney diseases market is expected to reach $128.15 billion in 2027 at a CAGR of 6.6%.

Download Free Sample Of Kidney Disease Market Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=11938&type=smp

Major competitors in the Kidney Disease market are Pfizer Inc., Johnson & Johnson Ltd., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi Aventis LLC, Bristol-Myers Squibb Company, AstraZeneca Pharmaceuticals LP, Abbott Laboratories, Fresenius SE & Co. KGaA, GlaxoSmithKline Plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Gilead Sciences Inc., Amgen Inc., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Vertex Pharmaceuticals Inc., Otsuka Pharmaceutical Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Kyowa Kirin Co. Ltd., Cipla Inc., Endo International plc., Lupin Limited, and Kissei Pharmaceutical Co. Lt.

A key trend in the Kidney Disease market includes Integration of AI-driven tools. Companies operating in the kidney disease market are adopting new technologies to facilitate improved patient outcomes and sustain their position in the market.

Read More On The Global Kidney Disease Market Report Here:
https://www.thebusinessresearchcompany.com/report/kidney-disease-global-market-report

The Kidney Disease market is segmented -
1) By Treatment: Medication, Dialysis, Surgery, Other Treatments
2) By Indication: Acute Kidney Injury, Chronic Kidney Disease, End-Stage Renal Disease, Other Indication
3) By Route Of Administration: Oral, Parenteral
4) By End-User: Hospitals, Diagnostic Laboratories, Other End-Users
• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the Kidney Disease market.

The Business Research Company's "Global Kidney Disease Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.

Explore Buying Options For The Kidney Disease Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11938

The Table Of Content For The Kidney Disease Market Include:
1. Executive Summary
2. Kidney Disease Market Characteristics
3. Kidney Disease Market Trends And Strategies
4. Kidney Disease Market - Macro Economic Scenario
5. Kidney Disease Market Size And Growth
........
32. Global Kidney Disease Market Competitive Benchmarking
33. Global Kidney Disease Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Kidney Disease Market
35. Kidney Disease Market Future Outlook and Potential Analysis
36. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Kidney Disease Market Report: Trends, Production, Revenue, Growth And Forecast To 2032 here

News-ID: 3218019 • Views:

More Releases from The Business research company

C-X-C Chemokine Receptor Type 2 Market on Track for Strong Growth, Estimated to Grow at 11.6% CAGR Through 2029
C-X-C Chemokine Receptor Type 2 Market on Track for Strong Growth, Estimated to …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the C-X-C Chemokine Receptor Type 2 Market Through 2025? There has been a significant expansion in the market for C-X-C chemokine receptor type 2 in the past few years. The market is projected to increase from $1.24 billion in 2024 to $1.38 billion
Top Market Shifts Transforming the Coenzyme Q10 Market Landscape: Key Insights
Top Market Shifts Transforming the Coenzyme Q10 Market Landscape: Key Insights
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Coenzyme Q10 Market Through 2025? The market size of coenzyme Q10 has seen impressive expansion in the past years, with predictions stating an increase from $0.74 billion in 2024 up to $0.84 billion in 2025, implying a compound annual growth rate (CAGR)
2025-2034 Chimeric Antibody Market Evolution: Disruptions, Innovations, and Untapped Opportunities
2025-2034 Chimeric Antibody Market Evolution: Disruptions, Innovations, and Unta …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Chimeric Antibody Market Through 2025? In recent times, there has been a swift expansion in the chimeric antibody market size. We can expect an increase from $12.27 billion in 2024 to $13.74 billion in 2025, reflecting a compound annual growth rate (CAGR)
2025-2034 Chimeric Antibody Market Evolution: Disruptions, Innovations, and Untapped Opportunities
2025-2034 Chimeric Antibody Market Evolution: Disruptions, Innovations, and Unta …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Chimeric Antibody Market Through 2025? In recent times, there has been a swift expansion in the chimeric antibody market size. We can expect an increase from $12.27 billion in 2024 to $13.74 billion in 2025, reflecting a compound annual growth rate (CAGR)

All 5 Releases


More Releases for Kidney

Wearable Artificial Kidney Market Development Trajectory through 2031 Dutch Kidn …
"[New York, December 2024] The Wearable Artificial Kidney represents a groundbreaking innovation in nephrology that combines advanced biomedical engineering with portable technology. Designed to continuously filter waste from the blood, this device caters primarily to patients with chronic kidney disease. As renal health issues become more prevalent globally, the relevance of the Wearable Artificial Kidney lies in its potential to enhance patient quality of life, providing a more convenient and
Kidney Dialysis Market Share Kidney Dialysis Market
According to Ameco Research 'Kidney Dialysis Market report, the analysts took this into account when estimating the Kidney Dialysis Market size and CAGR for the respective industry. The report's author has thoroughly examined the market and concluded that the Kidney Dialysis Market 's growth will level off in the coming years. In addition to that, the prominent qualitative information added in the report includes Kidney Dialysis Market trends, segmentation, key
Kidney Health Journey: Polycystic Kidney Disease Drug Pipeline Landscape (2023-2 …
Market Outlook: The Polycystic Kidney Disease (PKD) drug pipeline landscape is poised for noteworthy advancements, offering a positive outlook for those navigating the complex journey of kidney health. As PKD poses a significant global health burden, the market outlook reflects a pressing need for innovative pharmaceutical interventions to address the challenges associated with this genetic disorder. With ongoing research and development efforts, the PKD drug pipeline is positioned to bring
Kidney Balloon Market Growth Drives By Rising Prevalence of Kidney Stone and Oth …
Demand Analysis of Kidney Balloon Market Overview: Kidney Balloon Market is predicted to grow at a moderate CAGR of 5.2% during the forecast period covering 2022 to 2029. Kidney Balloon Market share is estimated to reach a value of nearly US$ 2.50 Billion by 2029. The "Kidney Balloon Market" think about 2022, the industry landscape is secured from driving factors to upstream markets and the by and large state of the market.
Kidney Transplant Market
Kidney Transplant Market describes its growth, size, share, Forecast and trends to 2025 Kidney transplant is the most commonly conducted transplant surgery worldwide. It has gained widespread popularity by improving the outcome of end-stage renal disease ESRD patients. With advances in kidney transplant methods and improvement in transplant success, a kidney transplant is now widely considered to be the best way of treating chronic kidney disease for many people. As the
Artificial Kidney Market Report 2018: Segmentation by Type (Wearable Artificial …
Global Artificial Kidney market research report provides company profile for Medtronic, DaVita, Merit Medical Systems, NIPRO Medical Corporation, Nikkiso, B. Braun Melsungen AG, Kawasumi Laboratories, Fresenius, Baxter, Asahi Kasei Medical, Xcorporeal and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for